Kossan Rubber Industries Bhd
KLSE:KOSSAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 5-Year Average (2.5), the stock would be worth MYR-0.04 (104% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -64.9 | MYR1.1 |
0%
|
| 5-Year Average | 2.5 | MYR-0.04 |
-104%
|
| Industry Average | 13.7 | MYR-0.23 |
-121%
|
| Country Average | 16.5 | MYR-0.28 |
-125%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| MY |
K
|
Kossan Rubber Industries Bhd
KLSE:KOSSAN
|
2.8B MYR | -64.9 | 18.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 48.7 | 37.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.8B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.4B CHF | 26.3 | 36.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
88.8B DKK | 18 | 22.8 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.8B USD | 26 | 31.1 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.8B USD | -25.4 | -16 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.1B GBP | 12.6 | 31.1 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
37.9B CNY | 33.7 | 23 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.3B CNY | 10.3 | 21.9 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.1T KRW | -115.1 | -36.5 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 10.7 |
| Median | 16.5 |
| 70th Percentile | 31.5 |
| Max | 143 415.1 |
Other Multiples
Kossan Rubber Industries Bhd
Glance View
In the bustling industrial hubs of Malaysia, Kossan Rubber Industries Bhd has established itself as a key player in the global rubber market. Founded in 1979, Kossan began its journey crafting rubber gloves and quickly recognized the potential of this essential product. The growth trajectory in recent decades reflected a keen ability to adapt to market demands, rooted in tireless innovation and strategic expansion. Kossan’s range of products primarily includes medical and industrial gloves, notably used in healthcare and manufacturing settings, covering a substantial slice of both sectors worldwide. This focus on high-quality, durable goods has enabled Kossan to secure its place as one of the world's largest glove manufacturers, earning a reputation for excellence across international markets. Kossan’s profitability springs from a well-honed operational model that capitalizes on both volume and value. The company operates a vertically integrated setup to maintain stringent quality controls, sourcing raw materials, and crafting products with precision. Integral to its success is Kossan's commitment to research and development, which propels innovative solutions like specialized coatings for better grip and comfort in gloves. With manufacturing plants strategically located to optimize production and distribution, Kossan efficiently taps into a global supply network, benefiting from cost efficiencies and market reach. Through this methodical approach, the company continuously supports and advances its supply chains, ensuring steady streams of revenue while responding to the ever-increasing demand for protective wear in medical and industrial spheres.